Chemotherapy Clinical Trials
143 recruitingDrug
Phase 268Phase 335Phase 125Not Applicable15Early Phase 11
Showing 1–20 of 143 trials
Recruiting
Phase 1
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
BeOne Medicines310 enrolled49 locationsNCT06596473
Recruiting
Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Advanced Solid TumorSolid Tumor
BeOne Medicines217 enrolled27 locationsNCT05981703
Recruiting
Phase 2
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Solid TumorsLymphoma
Spectrum Pharmaceuticals, Inc40 enrolled5 locationsNCT04570423
Recruiting
Phase 1
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Advanced Solid TumorMetastatic Solid Tumor
BeOne Medicines90 enrolled13 locationsNCT06803680
Recruiting
Phase 2
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Genentech, Inc.99 enrolled38 locationsNCT04302025
Recruiting
Phase 2
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital120 enrolled1 locationNCT07162506
Recruiting
Early Phase 1
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center120 enrolled1 locationNCT03594630
Recruiting
Phase 2Phase 3
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Endometrial Cancer
Leiden University Medical Center1,615 enrolled14 locationsNCT05255653
Recruiting
Not Applicable
Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Ewing SarcomaRound Cell Sarcoma With EWSR1-non-ETS Fusion
Mayo Clinic141 enrolled1 locationNCT07188532
Recruiting
Phase 3
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Stage IV Colorectal Cancer AJCC v8Metastatic Colorectal Adenocarcinoma
Alliance for Clinical Trials in Oncology364 enrolled183 locationsNCT05673148
Recruiting
Phase 3
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT05340491
Recruiting
Phase 3
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Phase 1
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
University of Maryland, Baltimore18 enrolled4 locationsNCT06800339
Recruiting
Phase 1
Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
NSCLCLeptomeningeal MetastasisLow Dose Radiotherapy+1 more
Sichuan University10 enrolled1 locationNCT06431685
Recruiting
Phase 1Phase 2
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II
Non-small Cell Lung Cancer
Sichuan University40 enrolled1 locationNCT06195189
Recruiting
Phase 2Phase 3
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
Esophageal CancerEsophageal CarcinomaGastric (Stomach) Cancer+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)290 enrolled2 locationsNCT07000253
Recruiting
Phase 2Phase 3
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
Locally Advanced Resectable Rectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.165 enrolled2 locationsNCT07454720
Recruiting
Phase 3
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Leukemia
Daiichi Sankyo700 enrolled288 locationsNCT06578247
Recruiting
Phase 3
Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Thymic Carcinoma
Fudan University172 enrolled1 locationNCT06402708
Recruiting
Phase 2
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University31 enrolled1 locationNCT06767007